Found 8 matching trials
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
PHASE1PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Location
PRA Health Sciences - Early Development Services
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
PHASE1A single dose dose study to assess the pharmacokinetics (PK) of oxycodone, ...
Location
Quotient Sciences
Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)
PHASE1A single dose study to assess the pharmacokinetics (PK) of oxycodone, when ...
Location
Quotient Sciences
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
PHASE1The purpose of this study is to examine the abuse potential and pharmacokin...
Location
Ohio Clinical Trails
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
PHASE2The primary objective of the study is to evaluate the onset of analgesia fo...
Location
Dr. Vince Clinical Research
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
PHASE3The goal of this clinical trial is to evaluate the analgesic activity of PF...
Location
CenExel / Atlanta Center for Medical Research (ACMR)
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
PHASE1This will be a randomized, double-blind, placebo- and active-controlled, 5-...
Location
Dr. Vince Clinical Research
Evaluation of Oral PF614 Relative to OxyContin (PF614-102)
PHASE1This is a single-center study incorporating 2 parts: A Multiple Ascending D...
Location
PRA Health Sciences-Early Development Services